Saxagliptin and Alogliptin Noninferior for CV Ischemic Events in Patients at High Risk with T2DM and Coronary Disease
Emma HittNichols
Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, USA (At time of ACC.06 publication, Cleveland Clinic Cardiovascular Coordinating Center, Cleveland, Ohio, USA)
Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, USA (At time of ACC.06 publication, Cleveland Clinic Cardiovascular Coordinating Center, Cleveland, Ohio, USA)
